NEW YORK--(BUSINESS WIRE)-- New York Genome Center (NYGC) today announced the formal commencement of their collaborative relationship with Illumina, initiated in November 2011, when Illumina was selected as the Center’s lead sequencing technology provider. As a next step in this collaboration, the Center will begin taking delivery of Illumina HiSeq 2000 and 2500 sequencing systems, creating the foundation for its pilot lab operations, which will commence in Manhattan this summer.
